161 related articles for article (PubMed ID: 6738078)
1. [Comparative biochemical and ultrastructural study of the hepatic response induced in the rat by 2 hypolipemic agents: clofibrate and itanoxone].
Gendre PM; Marcelon G; Delhon A; Lauressergues H; Fauran F
J Pharmacol; 1984; 15(2):209-22. PubMed ID: 6738078
[TBL] [Abstract][Full Text] [Related]
2. Comparative ultrastructural study of rat hepatocytes after treatment with the hypolipidemic agents probucol, clofibrate, and fenofibrate.
Barnard SD; Molello JA; Caldwell WJ; LeBeau JE
J Toxicol Environ Health; 1980 May; 6(3):547-57. PubMed ID: 7420463
[TBL] [Abstract][Full Text] [Related]
3. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
Amacher DE; Beck R; Schomaker SJ; Kenny CV
Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
[TBL] [Abstract][Full Text] [Related]
4. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
Flatmark T; Christiansen EN; Kryvi H
Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
[TBL] [Abstract][Full Text] [Related]
5. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat.
Stevens TJ; Stafford WW; Day CE; Block EM
Artery; 1983; 12(2):81-94. PubMed ID: 6678582
[TBL] [Abstract][Full Text] [Related]
7. Effect of hypolipidaemic drugs on hepatomegaly and micro-bodies in the rat. A new approach to the nature of hepatic peroxisomal proliferation.
Sim AK; Spencer A; Metz G; Rushton B
Arzneimittelforschung; 1981; 31(7):1119-26. PubMed ID: 7196761
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)].
Barnard SD; Molello JA; Caldwell WJ; Lebeau JE
Nouv Presse Med; 1980 Oct; 9(40):3005-7. PubMed ID: 7443440
[TBL] [Abstract][Full Text] [Related]
9. Aminophenyl ether compound (YM-95831), a new hypolipidemic agent with a high density lipoprotein elevating activity in rats.
Ohata I; Sakamoto N; Nitatori R; Maeno H
Arzneimittelforschung; 1983; 33(2):237-41. PubMed ID: 6682662
[TBL] [Abstract][Full Text] [Related]
10. Reversal of orotic acid-induced fatty liver in rats by clofibrate.
Novikoff PM; Edelstein D
Lab Invest; 1977 Feb; 36(2):215-31. PubMed ID: 839735
[TBL] [Abstract][Full Text] [Related]
11. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1987 Jan; 319():1-198. PubMed ID: 12748734
[TBL] [Abstract][Full Text] [Related]
14. Effects of clofibrate withdrawal on peroxisomes in mouse hepatocytes.
Meijer J; Starkerud C; Afzelius BA
Eur J Cell Biol; 1993 Apr; 60(2):291-9. PubMed ID: 8330627
[TBL] [Abstract][Full Text] [Related]
15. Proliferation of peroxisomes in pericentral hepatocytes of rat liver after administration of a new hypocholesterolemic agent (BM 15766). Sex-dependent ultrastructural differences.
Baumgart E; Stegmeier K; Schmidt FH; Fahimi HD
Lab Invest; 1987 May; 56(5):554-64. PubMed ID: 3573722
[TBL] [Abstract][Full Text] [Related]
16. Clofibrate hypocholesterolemia associated with increased hepatic copper.
Klevay LM
Drug Nutr Interact; 1983; 2(2):131-7. PubMed ID: 6678750
[TBL] [Abstract][Full Text] [Related]
17. [Effect of clofibrate on intracellular enzyme distribution in the rat liver].
Panchenko LF; Popova SV; Pirozhkov SV; Antonenkov VD
Tsitologiia; 1983 Nov; 25(11):1302-8. PubMed ID: 6659071
[TBL] [Abstract][Full Text] [Related]
18. [Effect of ethanol and clofibrate on the activity of lipid catabolism enzyme systems in rat liver].
Antonenko VD; Popova SV; Panchenko LF
Farmakol Toksikol; 1983; 46(5):86-90. PubMed ID: 6138280
[TBL] [Abstract][Full Text] [Related]
19. Effect of clofibrate on plasma lipid concentration and liver malic enzyme gene expression in rats with experimental chronic renal failure.
Korczyńska J; Stelmańska E; Nieweglowski T; Szołkiewicz M; Rutkowski B; Swierczyński J
Pol J Pharmacol; 2000; 52(4):291-7. PubMed ID: 11345485
[TBL] [Abstract][Full Text] [Related]
20. [Effects of 4-(4'-chlorobenzyloxy) benzyl nicotinate (KCD-232) on lipid metabolism in rats and mice].
Okada K; Mochizuki T; Shinohara Y; Takahashi S; Takagi K; Irikura T
Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):331-43. PubMed ID: 6745812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
